Breast Cancer Survivors Face Increased Cardiovascular Risks

Compared with those without cancer, older patients with breast cancer have a higher risk of developing cardiovascular disease, according to a study now published in the Journal of the National Comprehensive Cancer Network. "In older women diagnosed with breast cancer, there is now a greater likelihood of dying of diseases other than the cancer itself," write the investigators, led by first author Anthony Matthews, PhD, a postdoctoral researcher at the Karolinska Institute in Sweden. "Cardiovascu...
Continue reading

Incidence of Cardiotoxicity Induced by 5-FU and Capecitabine in Colorectal Cancer Patients

Fluoropyrimidines, such as 5-fluorouracil (5-FU) and capecitabine, are standards of care in treating gastrointestinal cancers, breast cancer, and head and neck cancers. However, both 5-FU and capecitabine can potentially induce cardiotoxicity that presents as acute coronary syndromes. A team of researchers led by Anne Dyhl-Polk, PhD of the Department of Oncology at the Herlev-Gentofte Hospital in Copenhagen, Denmark, set out to compare the incidence of cardiotoxicity caused by 5-FU and capecitab...
Continue reading

Copyright © 2021 Oncology Data Advisor. All rights reserved.